OTCMKTS:CHEOF

Cochlear Stock Forecast, Price & News

$155.13

-7.25 (-4.46%)

(As of 11/30/2021 03:29 PM ET)

Add

Compare

Today's Range: $150.50
▼
$160.00
50-Day Range: $155.13
▼
$171.00
52-Week Range: $137.75
▼
$185.30

Volume: 181 shs
Average Volume: 355 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive CHEOF News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

About Cochlear

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Valencia Technologies Strengthens Leadership Team with Key Appointments
November 29, 2021 | markets.businessinsider.com

Cochlear (OTCMKTS:CHEOF) Stock Price Down 0.8%
November 17, 2021 | americanbankingnews.com

Frequency Therapeutics Provides Business Updates and Third Quarter 2021 Financial Results
November 15, 2021 | benzinga.com

Alec Salt and Jared Hartsock Join Turner Scientific, LLC
November 1, 2021 | ca.finance.yahoo.com

Cochlear Reiterates FY Guidance Despite Covid Delays to Surgeries -- Update
October 18, 2021 | marketwatch.com

Cochlear announces FDA approval and FDA clearance of first-of-its-kind Remote Care capabilities for Nucleus and Baha Systems
October 12, 2021 | finance.yahoo.com

Brain Training takes Center Stage at NATO Symposium on Human Performance
October 9, 2021 | finance.yahoo.com

Hear and now: Railway hospital in Byculla runs out of cochlear implants
September 22, 2021 | msn.com

UAE: Dad elated as baby says 'mama, papa' after cochlear implant
August 31, 2021 | msn.com

$13 billion in JobKeeper payments went to companies that saw increased revenue in 2020, according to new data
August 30, 2021 | msn.com

Philips device recall leaves sleep apnoea sufferers in distress
August 27, 2021 | ft.com

Cochlear Limited 2021 Q4 - Results - Earnings Call Presentation
August 20, 2021 | seekingalpha.com

Highland Park Audiologist Adds Cochlear Implant Expert to Staff
August 11, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CHEOF
Previous Symbol
CUSIP: N/A
CIK: 1453930
Web: www.cochlear.com
Phone: (129) 428-6555
Fax: N/A
Employees: 4,000
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cochlear.

5.0 Community Rank

Outperform Votes
Cochlear has received 3 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cochlear has received 1 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cochlear has received 75.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote “Outperform” if you believe CHEOF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CHEOF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cochlear does not currently pay a dividend.
Dividend Growth
Cochlear does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cochlear insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Cochlear (OTCMKTS:CHEOF) Frequently Asked Questions

How has Cochlear's stock been impacted by Coronavirus?: Cochlear's stock was trading at $129.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CHEOF stock has increased by 20.3% and is now trading at $155.1250.
View which stocks have been most impacted by COVID-19.
Who are Cochlear's key executives?: Cochlear's management team includes the following people:
Diggory William Howitt, President, CEO, Executive Director & MD
Stuart Sayers, Chief Financial Officer & President-Services
Jan Janssen, Chief Technology Officer
David Hackshall, Chief Information Officer
Matthew Prior, VP-Finance & Commercial Operations-Asia Pacific
Who are some of Cochlear's key competitors?: Some companies that are related to Cochlear include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of CHEOF's competitors.
What is Cochlear's stock symbol?: Cochlear trades on the OTCMKTS under the ticker symbol "CHEOF."
How do I buy shares of Cochlear?: Shares of CHEOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cochlear's stock price today?: One share of CHEOF stock can currently be purchased for approximately $155.13.
How many employees does Cochlear have?: Cochlear employs 4,000 workers across the globe.
What is Cochlear's official website?: The official website for Cochlear is www.cochlear.com.
Where are Cochlear's headquarters?: Cochlear is headquartered at 1 University Avenue, Sydney, New South.
How can I contact Cochlear?: Cochlear's mailing address is 1 University Avenue, Sydney, New South. The company can be reached via phone at (129) 428-6555.

This page was last updated on 12/1/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Cochlear Stock Forecast, Price & News

About Cochlear

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

5.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Cochlear (OTCMKTS:CHEOF) Frequently Asked Questions

How has Cochlear's stock been impacted by Coronavirus?

Who are Cochlear's key executives?

Who are some of Cochlear's key competitors?

What is Cochlear's stock symbol?

How do I buy shares of Cochlear?

What is Cochlear's stock price today?

How many employees does Cochlear have?

What is Cochlear's official website?

Where are Cochlear's headquarters?

How can I contact Cochlear?